{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:58:18Z","timestamp":1770919098165,"version":"3.50.1"},"reference-count":63,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The COVID-19 pandemic has had a huge influence in almost all areas of life, affecting societies, economics, and health care systems worldwide. The paediatric cardiology community is no exception. As the challenging battle with COVID-19 continues, professionals from the Association for the European Paediatric and Congenital Cardiology receive many questions regarding COVID-19 in a Paediatric and Congenital Cardiology setting. The aim of this paper is to present the AEPC position on frequently asked questions based on the most recent scientific data, as well as to frame a discussion on how to take care of our patients during this unprecedented crisis. As the times are changing quickly and information regarding COVID-19 is very dynamic, continuous collection of evidence will help guide constructive decision-making.<\/jats:p>","DOI":"10.1017\/s1047951120005028","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T12:17:00Z","timestamp":1610021820000},"page":"344-351","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":10,"title":["COVID-19 FAQs in paediatric and congenital cardiology: AEPC position paper"],"prefix":"10.1017","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0242-9586","authenticated-orcid":false,"given":"Skaiste","family":"Sendzikaite","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0743-0823","authenticated-orcid":false,"given":"Ruth","family":"Heying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ornella","family":"Milanesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Hanseus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3131-573X","authenticated-orcid":false,"given":"Ina","family":"Michel-Behnke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"S1047951120005028_ref29","first-page":"133","article-title":"A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process","author":"Harwood","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"S1047951120005028_ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2007617"},{"key":"S1047951120005028_ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7"},{"key":"S1047951120005028_ref46","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaa045"},{"key":"S1047951120005028_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"S1047951120005028_ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.1948"},{"key":"S1047951120005028_ref53","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-1053-9"},{"key":"S1047951120005028_ref25","unstructured":"25. WHO. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. 15 May 2020. https:\/\/www.who.int\/news-room\/commentaries\/detail\/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19"},{"key":"S1047951120005028_ref61","unstructured":"61. WHO Draft landscape of COVID-19 candidate vaccine 22 September 2020. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines"},{"key":"S1047951120005028_ref27","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6932e2"},{"key":"S1047951120005028_ref28","unstructured":"28. DGPI. Hyperinflammationssyndrom im Zusammenhang mit COVID-19 2020. https:\/\/dgpi.de\/stellungnahme-dgpi-dgpk-hyperinflammationssyndrom-covid-19\/"},{"key":"S1047951120005028_ref10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0702"},{"key":"S1047951120005028_ref52","article-title":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report","author":"Group","year":"2020","journal-title":"N Engl J Med"},{"key":"S1047951120005028_ref43","first-page":"1848","article-title":"Antibodies in infants born to mothers with COVID-19 pneumonia","volume":"323","author":"Zeng","year":"2020","journal-title":"JAMA"},{"key":"S1047951120005028_ref59","unstructured":"59. CCS. GUIDANCE FROM THE CCS COVID-19 RAPID RESPONSE TEAM COVID-19 and Cardiovascular Disease: What the Cardiac Healthcare Provider Should Know 2020. https:\/\/www.pediatriccardiaclearningcenter.org\/guidelines\/covid19\/covid-cardiovascular-disease-mar2020-canadian-cardiovascular-society.pdf"},{"key":"S1047951120005028_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31094-1"},{"key":"S1047951120005028_ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021680"},{"key":"S1047951120005028_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.04.026"},{"key":"S1047951120005028_ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10369"},{"key":"S1047951120005028_ref45","unstructured":"45. CDC. Considerations for Inpatient Obstetric Healthcare Settings 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/inpatient-obstetric-healthcare-guidance.html"},{"key":"S1047951120005028_ref32","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0834"},{"key":"S1047951120005028_ref63","unstructured":"63. CDC. Discontinuation of transmission-based precautions and disposition of patients with COVID-19 in Healthcare Settings (Interim Guidance) 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/disposition-hospitalized-patients.html"},{"key":"S1047951120005028_ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.04.065"},{"key":"S1047951120005028_ref62","first-page":"2150135120924653","article-title":"COVID-19 FAQ\u2019s in pediatric cardiac surgery","volume":"11","author":"Levy","year":"2020","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"S1047951120005028_ref13","doi-asserted-by":"publisher","DOI":"10.7326\/M20-4986"},{"key":"S1047951120005028_ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13925"},{"key":"S1047951120005028_ref60","doi-asserted-by":"publisher","DOI":"10.1002\/art.41095"},{"key":"S1047951120005028_ref36","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"S1047951120005028_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.03.024"},{"key":"S1047951120005028_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrcr.2020.03.012"},{"key":"S1047951120005028_ref41","first-page":"1846","article-title":"Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn","volume":"323","author":"Dong","year":"2020","journal-title":"JAMA"},{"key":"S1047951120005028_ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"S1047951120005028_ref34","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28346"},{"key":"S1047951120005028_ref18","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa106"},{"key":"S1047951120005028_ref14","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa078"},{"key":"S1047951120005028_ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1096"},{"key":"S1047951120005028_ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2005073"},{"key":"S1047951120005028_ref48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"S1047951120005028_ref44","first-page":"1788","article-title":"Can SARS-CoV-2 infection be acquired in utero? More definitive evidence is needed","volume":"323","author":"Kimberlin","year":"2020","journal-title":"JAMA"},{"key":"S1047951120005028_ref55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007193230304"},{"key":"S1047951120005028_ref24","unstructured":"24. Prevention TCfDCa. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). May 14, 2020. https:\/\/emergency.cdc.gov\/han\/2020\/han00432.asp"},{"key":"S1047951120005028_ref37","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0901-SA"},{"key":"S1047951120005028_ref56","unstructured":"56. CCS. GUIDANCE FROM THE CCS COVID-19 RAPID RESPONSE TEAM UPDATED - COVID-19 and concerns regarding use of cardiovascular medications, including ACEi\/ARB\/ARNi, low-dose ASA and non-steroidal anti-inflammatory drugs (NSAIDS) 2020. http:\/\/www.ccs.ca\/images\/Images_2020\/CCS_CHFS_Update_COVID__CV_medications_Mar20.pdf"},{"key":"S1047951120005028_ref47","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-1081"},{"key":"S1047951120005028_ref33","first-page":"E103","article-title":"Resource allocation and decision making for pediatric and congenital cardiac catheterization during the novel coronavirus SARS-CoV-2 (COVID-19) pandemic: a U.S. multi-institutional perspective","volume":"32","author":"Morray","year":"2020","journal-title":"J Invasive Cardiol."},{"key":"S1047951120005028_ref8","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.18.2000600"},{"key":"S1047951120005028_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.04.013"},{"key":"S1047951120005028_ref50","unstructured":"50. NIH. Potential Antiviral Drugs Under Evaluation for the Treatment of COVID-19 2020. https:\/\/www.covid19treatmentguidelines.nih.gov\/antiviral-therapy\/"},{"key":"S1047951120005028_ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1828"},{"key":"S1047951120005028_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31103-X"},{"key":"S1047951120005028_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2020.03.063"},{"key":"S1047951120005028_ref42","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.0878"},{"key":"S1047951120005028_ref49","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"S1047951120005028_ref51","unstructured":"51. NIH. Corticosteroids. Recommendations for Patients with COVID-19. August 27, 2020. https:\/\/www.covid19treatmentguidelines.nih.gov\/immune-based-therapy\/immunomodulators\/corticosteroids\/"},{"key":"S1047951120005028_ref5","unstructured":"5. ESC. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic 2020. https:\/\/www.escardio.org\/Education\/COVID-19-and-Cardiology\/ESC-COVID-19-Guidance"},{"key":"S1047951120005028_ref58","unstructured":"58. WHO. Q&A: Hydroxychloroquine and COVID-19. 19 June 2020. https:\/\/www.who.int\/news-room\/q-a-detail\/coronavirus-disease-covid-19-hydroxychloroquine"},{"key":"S1047951120005028_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.05.007"},{"key":"S1047951120005028_ref54","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28485"},{"key":"S1047951120005028_ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0689-4"},{"key":"S1047951120005028_ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.03.034"},{"key":"S1047951120005028_ref12","unstructured":"12. Association BCC. https:\/\/www.pediatriccardiaclearningcenter.org\/guidelines\/covid19\/british-congenital-cardiac-association-2020.pdf2020"},{"key":"S1047951120005028_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(20)30257-1"},{"key":"S1047951120005028_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.04.027"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951120005028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T09:55:26Z","timestamp":1662717326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951120005028\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1047951120005028"],"URL":"https:\/\/doi.org\/10.1017\/s1047951120005028","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"value":"1047-9511","type":"print"},{"value":"1467-1107","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"\u00a9 The Author(s), 2021. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}